Possible role of EBV in breast cancer and other unusually EBV-associated cancers

Cancer Letters

Volumn 305, Issue 2, 2011, Pages 144-149

  Hippocrate, Aurélie ^a   Oussaief, Lassad ^a   Joab, Irène ^a  

^a INSERM U1014   (France)

Author keywords

Carcinoma; Epstein Barr virus; Tumor progression

Indexed keywords

EPSTEIN BARR VIRUS ANTIGEN 1; VIRUS DNA;

ARTICLE; BREAST CANCER; BURKITT LYMPHOMA; CANCER GROWTH; CANCER RISK; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; HUMAN; LYMPHOEPITHELIOMA; NASOPHARYNX CARCINOMA; NEOPLASM; NONHUMAN; PRIORITY JOURNAL; RISK FACTOR; STOMACH CANCER; VIRUS CARCINOGENESIS; VIRUS GENOME; WARTHIN TUMOR;

HERPESVIRIDAE; HUMAN HERPESVIRUS 4;

EID: 79955481317     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2010.11.007     Document Type: Article

References (60)

1. Babcock G.J., Decker L.L., Volk M., Thorley-Lawson D.A. EBV persistence in memory B cells in vivo. Immunity 1998, 9:395-404.
2. Young L.S., Rickinson A.B. Epstein-Barr virus: 40years on. Nat. Rev. Cancer 2004, 4:757-768.
3. Imai S., Nishikawa J., Takada K. Cell-to-cell contact as an efficient mode of Epstein-Barr virus infection of diverse human epithelial cells. J. Virol. 1998, 72:4371-4378.
4. Borza C.M., Hutt-Fletcher L.M. Alternate replication in B cells and epithelial cells switches tropism of Epstein-Barr virus. Nat. Med. 2002, 8:594-599.
5. Lo K.W., Huang D.P. Genetic and epigenetic changes in nasopharyngeal carcinoma. Semin. Cancer Biol. 2002, 12:451-462.
6. Zur Hausen A., van Rees B.P., van Beek J., Craanen M.E., Bloemena E., Offerhaus G.J., Meijer C.J., van den Brule A.J. Epstein-Barr virus in gastric carcinomas and gastric stump carcinomas: a late event in gastric carcinogenesis. J. Clin. Pathol. 2004, 57:487-491.
7. Rickinson A.B., Kieff E. Epstein-Barr virus. Fields' Virology 2007, 2655-2700. Lippincott William & Wilkins, Philadelphia. D.K.P. Howley (Ed.).
8. Niedobitek G., Hansmann M.L., Herbst H., Young L.S., Dienemann D., Hartmann C.A., Finn T., Pitteroff S., Welt A., Anagnostopoulos I., et al. Epstein-Barr virus and carcinomas: undifferentiated carcinomas but not squamous cell carcinomas of the nasopharynx are regularly associated with the virus. J. Pathol. 1991, 165:17-24.
9. Gilligan K., Sato H., Rajadurai P., Busson P., Young L., Rickinson A., Tursz T., Raab-Traub N. Novel transcription from the Epstein-Barr virus terminal EcoRI fragment, DIJhet, in a nasopharyngeal carcinoma. J. Virol. 1990, 64:4948-4956.
10. Takeuchi H., Kobayashi R., Hasegawa M., Hirai K. Detection of latent Epstein-Barr virus (EBV) DNA in paraffin sections of nasopharyngeal carcinomas expressing no EBV-encoded small RNAs using in situ PCR. Arch. Virol. 1997, 142:1743-1756.
11. Yao Y., Minter H.A., Chen X., Reynolds G.M., Bromley M., Arrand J.R. Heterogeneity of HLA and EBER expression in Epstein-Barr virus-associated nasopharyngeal carcinoma. Int. J. Cancer 2000, 88:949-955.
12. Pagano J.S., Blaser M., Buendia M.A., Damania B., Khalili K., Raab-Traub N., Roizman B. Infectious agents and cancer: criteria for a causal relation. Semin. Cancer Biol. 2004, 14:453-471.
13. Arbach H., Viglasky V., Lefeu F., Guinebretiere J.M., Ramirez V., Bride N., Boualaga N., Bauchet T., Peyrat J.P., Mathieu M.C., Mourah S., Podgorniak M.P., Seignerin J.M., Takada K., Joab I. Epstein-Barr virus (EBV) genome and expression in breast cancer tissue: effect of EBV infection of breast cancer cells on resistance to paclitaxel (Taxol). J. Virol. 2006, 80:845-853.
14. Tsai C.C., Chen C.L., Hsu H.C. Expression of Epstein-Barr virus in carcinomas of major salivary glands: a strong association with lymphoepithelioma-like carcinoma. Hum. Pathol. 1996, 27:258-262.
15. Sashiyama H., Nozawa A., Kimura M., Nomura E., Tamaru J.I., Ninomiya E., Koide Y., Iino M., Ozawa K. Case report: a case of lymphoepithelioma-like carcinoma of the oesophagus and review of the literature. J. Gastroenterol. Hepatol. 1999, 14:534-539.
16. Burke A.P., Yen T.S., Shekitka K.M., Sobin L.H. Lymphoepithelial carcinoma of the stomach with Epstein-Barr virus demonstrated by polymerase chain reaction. Mod. Pathol. 1990, 3:377-380.
17. De Petris G., Lev R., Quirk D.M., Ferbend P.R., Butmarc J.R., Elenitoba-Johnson K. Lymphoepithelioma-like carcinoma of the colon in a patient with hereditary nonpolyposis colorectal cancer. Arch. Pathol. Lab. Med. 1999, 123:720-724.
18. Vortmeyer A.O., Kingma D.W., Fenton R.G., Curti B.D., Jaffe E.S., Duray P.H. Hepatobiliary lymphoepithelioma-like carcinoma associated with Epstein-Barr virus. Am. J. Clin. Pathol. 1998, 109:90-95.
19. Leung S.Y., Yuen S.T., Ho C.M., Kwong W.K., Chung L.P. Presence of Epstein-Barr virus in lymphoepithelioma-like carcinoma of the middle ear. J. Clin. Pathol. 1998, 51:602-605.
20. Andryk J., Freije J.E., Schultz C.J., Campbell B.H., Komorowski R.A. Lymphoepithelioma of the larynx. Am. J. Otolaryngol. 1996, 17:61-63.
21. Leyvraz S., Henle W., Chahinian A.P., Perlmann C., Klein G., Gordon R.E., Rosenblum M., Holland J.F. Association of Epstein-Barr virus with thymic carcinoma. N. Engl. J. Med. 1985, 312:1296-1299.
22. Sasagawa T., Shimakage M., Nakamura M., Sakaike J., Ishikawa H., Inoue M. Epstein-Barr virus (EBV) genes expression in cervical intraepithelial neoplasia and invasive cervical cancer: a comparative study with human papillomavirus (HPV) infection. Hum. Pathol. 2000, 31:318-326.
23. Holmang S., Borghede G., Johansson S.L. Bladder carcinoma with lymphoepithelioma-like differentiation: a report of 9 cases. J. Urol. 1998, 159:779-782.
24. Shek T.W., Leung E.Y., Luk I.S., Loong F., Chan A.C., Yik Y.H., Lam L.K. Lymphoepithelioma-like carcinoma of the skin. Am. J. Dermatopathol. 1996, 18:637-644.
25. Hsu J.L., Glaser S.L. Epstein-Barr virus-associated malignancies: epidemiologic patterns and etiologic implications. Crit. Rev. Oncol. Hematol. 2000, 34:27-53.
26. Kotsianti A., Costopoulos J., Morgello S., Papadimitriou C. Undifferentiated carcinoma of the parotid gland in a white patient: detection of Epstein-Barr virus by in situ hybridization. Hum. Pathol. 1996, 27:87-90.
27. Kohrenhagen N., Eck M., Holler S., Dietl J. Lymphoepithelioma-like carcinoma of the uterine cervix: absence of Epstein-Barr virus and high-risk human papilloma virus infection. Arch. Gynecol. Obstet. 2008, 277:175-178.
28. Sixbey J.W., Lemon S.M., Pagano J.S. A second site for Epstein-Barr virus shedding: the uterine cervix. Lancet 1986, 2:1122-1124.
29. Tseng C.J., Pao C.C., Tseng L.H., Chang C.T., Lai C.H., Soong Y.K., Hsueh S., Jyu-Jen H. Lymphoepithelioma-like carcinoma of the uterine cervix: association with Epstein-Barr virus and human papillomavirus. Cancer 1997, 80:91-97.
30. Iezzoni J.C., Gaffey M.J., Weiss L.M. The role of Epstein-Barr virus in lymphoepithelioma-like carcinomas. Am. J. Clin. Pathol. 1995, 103:308-315.
31. Shibata D., Tokunaga M., Uemura Y., Sato E., Tanaka S., Weiss L.M. Association of Epstein-Barr virus with undifferentiated gastric carcinomas with intense lymphoid infiltration. Lymphoepithelioma-like carcinoma. Am. J. Pathol. 1991, 139:469-474.
32. Shibata D., Weiss L.M. Epstein-Barr virus-associated gastric adenocarcinoma. Am. J. Pathol. 1992, 140:769-774.
33. Parkin D.M., Pisani P., Ferlay J. Estimates of the worldwide incidence of 25 major cancers in 1990. Int. J. Cancer 1999, 80:827-841.
34. Talvensaari-Mattila A., Paakko P., Turpeenniemi-Hujanen T. Matrix metalloproteinase-2 (MMP-2) is associated with survival in breast carcinoma. Br. J. Cancer 2003, 89:1270-1275.
35. Tsutsui S., Ohno S., Murakami S., Kataoka A., Kinoshita J., Hachitanda Y., EGFR c-erbB2 and p53 protein in the primary lesions and paired metastatic regional lymph nodes in breast cancer. Eur. J. Surg. Oncol. 2002, 28:383-387.
36. van Netten J.P., Thornton I.G., Carlyle S.J., Brigden M.L., Coy P., Goodchild N.L., Gallagher S., George E.J. Multiple microsample analysis of intratumor estrogen receptor distribution in breast cancers by a combined biochemical/immunohistochemical method. Eur. J. Cancer Clin. Oncol. 1987, 23:1337-1342.
37. Richardson A. Is breast cancer caused by late exposure to a common virus?. Med. Hypotheses 1997, 48:491-497.
38. Yasui Y., Potter J.D., Stanford J.L., Rossing M.A., Winget M.D., Bronner M., Daling J. Breast cancer risk and "delayed" primary Epstein-Barr virus infection. Cancer Epidemiol. Biomarkers Prev. 2001, 10:9-16.
39. G. Contesso, F. Bertin, M.C. Mathieu, P. Terrier, Anatomie pathologique des cancers mammaires, in: E.m.e. Chirurgicale, (Ed.), techniques éditions, 1991.
40. Chu P.G., Chang K.L., Chen Y.Y., Chen W.G., Weiss L.M. No significant association of Epstein-Barr virus infection with invasive breast carcinoma. Am. J. Pathol. 2001, 159:571-578.
41. Bonnet M., Guinebretiere J.M., Kremmer E., Grunewald V., Benhamou E., Contesso G., Joab I. Detection of Epstein-Barr virus in invasive breast cancers. J. Natl. Cancer Inst. 1999, 91:1376-1381.
42. Herrmann K., Niedobitek G. Lack of evidence for an association of Epstein-Barr virus infection with breast carcinoma. Breast Cancer Res. 2003, 5:R13-17.
43. Murray P.G., Lissauer D., Junying J., Davies G., Moore S., Bell A., Timms J., Rowlands D., McConkey C., Reynolds G.M., Ghataura S., England D., Caroll R., Young L.S. Reactivity with a monoclonal antibody to Epstein-Barr virus (EBV) nuclear antigen 1 defines a subset of aggressive breast cancers in the absence of the EBV genome. Cancer Res. 2003, 63:2338-2343.
44. Gaffey M.J., Frierson H.F., Mills S.E., Boyd J.C., Zarbo R.J., Simpson J.F., Gross L.K., Weiss L.M. Medullary carcinoma of the breast. Identification of lymphocyte subpopulations and their significance. Mod. Pathol. 1993, 6:721-728.
45. Lespagnard L., Cochaux P., Larsimont D., Degeyter M., Velu T., Heimann R. Absence of Epstein-Barr virus in medullary carcinoma of the breast as demonstrated by immunophenotyping, in situ hybridization and polymerase chain reaction. Am. J. Clin. Pathol. 1995, 103:449-452.
46. Glaser S.L., Hsu J.L., Gulley M.L. Epstein-Barr virus and breast cancer: state of the evidence for viral carcinogenesis. Cancer Epidemiol. Biomarkers Prev. 2004, 13:688-697.
47. Arbach H., Joab I. EBV and breast cancer: questions and implications. Epstein-Barr Virus 2005, 139-155. Caister, Norfolk. E.S. Robertson (Ed.).
48. Fina F., Romain S., Ouafik L., Palmari J., Ben Ayed F., Benharkat S., Bonnier P., Spyratos F., Foekens J.A., Rose C., Buisson M., Gerard H., Reymond M.O., Seigneurin J.M., Martin P.M. Frequency and genome load of Epstein-Barr virus in 509 breast cancers from different geographical areas. Br. J. Cancer 2001, 84:783-790.
49. Labrecque L.G., Barnes D.M., Fentiman I.S., Griffin B.E. Epstein-Barr virus in epithelial cell tumors: a breast cancer study. Cancer Res. 1995, 55:39-45.
50. Shousha L. Presence of Epstein Barr virus in breast carcinoma. Int. J. Oncol. 1995, 6:899-903.
51. Grinstein S., Preciado M.V., Gattuso P., Chabay P.A., Warren W.H., De Matteo E., Gould V.E. Demonstration of Epstein-Barr virus in carcinomas of various sites. Cancer Res. 2002, 62:4876-4878.
52. Hennard C., Pfuhl T., Buettner M., Becker K.F., Knofel T., Middeldorp J., Kremmer E., Niedobitek G., Grasser F. The antibody 2B4 directed against the Epstein-Barr virus (EBV)-encoded nuclear antigen 1 (EBNA1) detects MAGE-4: implications for studies on the EBV association of human cancers. J. Pathol. 2006, 209:430-435.
53. Joshi D., Quadri M., Gangane N., Joshi R. Association of Epstein Barr virus infection (EBV) with breast cancer in rural Indian women. PLoS One 2009, 4:e8180.
54. Fawzy S., Sallam M., Awad N.M. Detection of Epstein-Barr virus in breast carcinoma in Egyptian women. Clin. Biochem. 2008, 41:486-492.
55. Huang J., Chen H., Hutt-Fletcher L., Ambinder R.F., Hayward S.D. Lytic viral replication as a contributor to the detection of Epstein-Barr virus in breast cancer. J. Virol. 2003, 77:13267-13274.
56. Delecluse H.J., Marafioti T., Hummel M., Dallenbach F., Anagnostopoulos I., Stein H. Disappearance of the Epstein-Barr virus in a relapse of Hodgkin's disease. J. Pathol. 1997, 182:475-479.
57. Perrigoue J.G., den Boon J.A., Friedl A., Newton M.A., Ahlquist P., Sugden B. Lack of association between EBV and breast carcinoma. Cancer Epidemiol. Biomarkers Prev. 2005, 14:809-814.
58. Aggarwal B.B., Shishodia S., Sandur S.K., Pandey M.K., Sethi G. Inflammation and cancer: how hot is the link?. Biochem. Pharmacol. 2006, 72:1605-1621.
59. Gilad S., Meiri E., Yogev Y., Benjamin S., Lebanony D., Yerushalmi N., Benjamin H., Kushnir M., Cholakh H., Melamed N., Bentwich Z., Hod M., Goren Y., Chajut A. Serum microRNAs are promising novel biomarkers. PLoS One 2008, 3:e3148.
60. Wang Z., Luo F., Li L., Yang L., Hu D., Ma X., Lu Z., Sun L., Cao Y. STAT3 activation induced by Epstein-Barr virus latent membrane protein1 causes vascular endothelial growth factor expression and cellular invasiveness via JAK3 and ERK signaling. Eur. J. Cancer 2010, 46:2996-3006.